(19)
(11) EP 1 296 942 A1

(12)

(43) Date of publication:
02.04.2003 Bulletin 2003/14

(21) Application number: 01943189.9

(22) Date of filing: 21.06.2001
(51) International Patent Classification (IPC)7C07C 275/24, C07C 275/28, C07C 237/20, C07C 237/32, C07D 209/48, C07D 213/36, C07D 277/62, A61K 31/166, A61K 31/167, A61K 31/17, A61K 31/429, A61K 31/4035, A61K 31/44, A61P 3/04, A61P 3/10
(86) International application number:
PCT/DK0100/435
(87) International publication number:
WO 0200/0612 (03.01.2002 Gazette 2002/01)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 23.06.2000 DK 200000984
17.11.2000 DK 200001734

(71) Applicant: Novo Nordisk A/S
2880 Bagsvaerd (DK)

(72) Inventors:
  • JOERGENSEN, Anker, Steen
    DK-2100 K benhavn (DK)
  • CHRISTENSEN, Inge, Thoeger
    DK-2800 Lyngby (DK)
  • KODRA, Janos, Tibor
    DK-2100 K benhavn (DK)
  • MADSEN, Peter
    DK-2880 Bagsv rd (DK)
  • BEHRENS, Carsten
    DK-2200 K benhavn N (DK)
  • SAMS, Christian
    DK-1973 Frederiksberg C (DK)
  • LAU, Jesper
    DK-3520 Farum (DK)

(74) Representative: Stahr, Pia et al
Novo Nordisk A/S,Corporate Patents,Novo Allé
2880 Bagsvaerd
2880 Bagsvaerd (DK)

   


(54) GLUCAGON ANTAGONISTS/INVERSE AGONISTS